Naamah Zitomersky, MD
Gastroenterologist, Division of Gastroenterology, Hepatology and Nutrition
Assistant Professor of Pediatrics, Harvard Medical School
Image
Naamah Zitomersky, MD
Gastroenterologist, Division of Gastroenterology, Hepatology and Nutrition
Assistant Professor of Pediatrics, Harvard Medical School
Medical Services
Languages
English
Media
Caregiver Profile
Meet Dr. Naamah Zitomersky
Professional History
Selected Publications
- Zitomersky, NL, Coyne, M, Comstock, LE. "Longitudinal analysis of the abundance and maintenance of the Bacteroidales species in the human gut." , May 2011 Infect Immun. Issue: 79(5) , Page: 2012-2020
- Zitomersky, NL, Verhave, M, Trenor III, CC. "Thrombosis and Inflammatory Bowel Disease A call for improved awareness and prevention." , Jan 2011 Inflammatory Bowel Diseases Issue: 17(1) , Page: 458-470
- Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. Zitomersky NL, Atkinson BJ, Franklin SW, Mitchell PD, Snapper SB, Comstock LE, Bousvaros A. PLoS One. 2013 Jun 11;8(6):e63686. doi: 10.1371/journal.pone.0063686. Print 2013.
- Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. Zitomersky NL, Levine AE, Atkinson BJ, Harney KM, Verhave M, Bousvaros A, Lightdale JR, Trenor CC 3rd. J Pediatr Gastroenterol Nutr. 2013 Sep;57(3):343-7. doi: 10.1097/MPG.0b013e31829ce5cd.
Publications
Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease. View Abstract
The Impact of Combination Therapy on Infliximab Levels and Antibodies in Children and Young Adults With Inflammatory Bowel Disease. View Abstract
ADAMTS13 Deficiency Worsens Colitis and Exogenous ADAMTS13 Administration Decreases Colitis Severity in Mice. View Abstract
13-year-old girl with recurrent, episodic, persistent vomiting: out of the pot and into the fire. View Abstract
Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD. View Abstract
PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock. View Abstract
Evidence of extensive DNA transfer between bacteroidales species within the human gut. View Abstract
Authors' response. View Abstract
Risk factors, morbidity, and treatment of thrombosis in children and young adults with active inflammatory bowel disease. View Abstract
Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. View Abstract
Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literature. View Abstract
Longitudinal analysis of the prevalence, maintenance, and IgA response to species of the order Bacteroidales in the human gut. View Abstract
Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention. View Abstract
Glypican-3 expression in Wilms tumor and hepatoblastoma. View Abstract
Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope. View Abstract
Locations